Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Schulz-Quach

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Cancers|January 21, 2023
A Phase II, Open-Label Clinical Trial of Intranasal Ketamine for Depression in Patients with Cancer Receiving Palliative Care (INKeD-PC Study)Joshua D Rosenblat, Froukje E deVries, Zoe Doyle, et al.
Journal of Psychopharmacology (Oxford, England)|July 1, 2025
Examining mystical experiences as a predictor of psilocybin-assisted psychotherapy for treatment-resistant depressionRyan M Brudner, Erica Kaczmarek, Marc G Blainey, et al.
Current Oncology (Toronto, Ont.)|July 25, 2025
Collecting Data on the Social Determinants of Health to Advance Health Equity in Cancer Care in Canada: Patient and Community PerspectivesJacqueline L Bender, Eryn Tong, Ekaterina An, et al.
Journal of Pain and Symptom Management|April 29, 2026
Intranasal Ketamine for Existential Distress in Advanced CancerStefan Aguiar, Mary Makarious, Orly Lipsitz, et al.
BMC Emergency Medicine|January 12, 2025
Understanding and measuring workplace violence in healthcare: a Canadian systematic framework to address a global healthcare phenomenonChristian Schulz-Quach, Brendan Lyver, Charlene Reynolds, et al.
Med (New York, N.Y.)|February 15, 2024
Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybinJoshua D Rosenblat, Shakila Meshkat, Zoe Doyle, et al.
International Journal of Clinical and Health Psychology : IJCHP|August 25, 2021
An international study on psychological coping during COVID-19: Towards a meaning-centered coping styleNikolett Eisenbeck, David F Carreno, Paul T P Wong, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Cancers|January 21, 2023
A Phase II, Open-Label Clinical Trial of Intranasal Ketamine for Depression in Patients with Cancer Receiving Palliative Care (INKeD-PC Study)Joshua D Rosenblat, Froukje E deVries, Zoe Doyle, et al.
Journal of Psychopharmacology (Oxford, England)|July 1, 2025
Examining mystical experiences as a predictor of psilocybin-assisted psychotherapy for treatment-resistant depressionRyan M Brudner, Erica Kaczmarek, Marc G Blainey, et al.
Current Oncology (Toronto, Ont.)|July 25, 2025
Collecting Data on the Social Determinants of Health to Advance Health Equity in Cancer Care in Canada: Patient and Community PerspectivesJacqueline L Bender, Eryn Tong, Ekaterina An, et al.
Journal of Pain and Symptom Management|April 29, 2026
Intranasal Ketamine for Existential Distress in Advanced CancerStefan Aguiar, Mary Makarious, Orly Lipsitz, et al.
BMC Emergency Medicine|January 12, 2025
Understanding and measuring workplace violence in healthcare: a Canadian systematic framework to address a global healthcare phenomenonChristian Schulz-Quach, Brendan Lyver, Charlene Reynolds, et al.
Med (New York, N.Y.)|February 15, 2024
Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybinJoshua D Rosenblat, Shakila Meshkat, Zoe Doyle, et al.
International Journal of Clinical and Health Psychology : IJCHP|August 25, 2021
An international study on psychological coping during COVID-19: Towards a meaning-centered coping styleNikolett Eisenbeck, David F Carreno, Paul T P Wong, et al.
Pageof 3